Findings showed MELT-300 was statistically superior to both sublingual midazolam and placebo for providing successful procedural sedation. Topline results were announced from a phase 3 trial ...

The FDA has approved Byfavo™ (remimazolam; Acacia Pharma) for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less. The Food and Drug ...

Please provide your email address to receive an email when new articles are posted on . Conscious sedation was not superior to general anesthesia for functional recovery in patients undergoing ...

Objectives: Although generally effective for sedation during noninvasive procedures, dexmedetomidine as the sole agent has not been uniformly successful for invasive procedures. To overcome some of ...

AMSTERDAM — Many urologic procedures can be safely performed with the use of conscious sedation rather than general anesthesia, and both clinicians and their patients say they prefer the lighter touch ...

The American Association of Nurse Anesthetists offers a free, downloadable brochure for patients which provides answers to questions about conscious sedation. What is conscious sedation? When is ...

Conscious sedation during TAVR is increasingly common in the United States and is linked to better outcomes than procedures using general anesthesia and endotracheal intubation, but there is still ...

Please provide your email address to receive an email when new articles are posted on . Not fasting before cardiac catheterization procedures with conscious sedation was just as safe as fasting.

The practice of using conscious sedation instead of general anesthesia for TAVR has increased in recent years and is associated with better survival and less time spent in the hospital, according to ...

This article was written by Tamara Wagner, BS, CPC, Vice President of Coding and Diana Hilliard, JD, Manager Managed Care Contracts for National Medical Billing Services. The AMA recently issued an ...

Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...